CSI Market
Sign In | Register

Inovio Pharmaceuticals Inc (INO) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access INO Annual Cash Flow →
The cash flow figures below highlight longer-term patterns in how Inovio Pharmaceuticals Inc manages cash inflows and outflows over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
6 Months 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income-25.70
Depreciation & amortization0.64
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation1.47
Income (Loss) from Equity Method Investments0.00
Fair Value Adjustment of Warrants-18.01
Change In Value Of Common Stock Warrants-
Change In Value Of Short Term Investments Auction Rate Securities-
Change In Value Of Auction Rate Security Rights-
Interest Income Accrued On Short Term Investments Certificates Of Deposit-
Reserve For Inventory Purchased From Related Parties-
Recognition Amortization Of Deferred Tax Liabilities-
Increase Decrease In Deferred Rent Receivables-
Impairment Of Long Term Investments-
Change In Value Of Investments In Affiliated Company2.10
Gain From Long Term Investment In Affiliated Entity-
Increase Decrease In Prepaid Expenses And Other Current Assets From Affiliated Entity-
Investment Income Amortization Of Premium-
Increase Decrease In Contract With Customer Liability-
Increase Decrease In Deferred Revenue From Related Parties-
Increase Decrease In Operating Lease Right Of Use Asset Lease Liability Net-0.67
Equity Securities Fv Ni Unrealized Loss-
Equity Securities Fv Ni Unrealized Gain Loss-0.08
Operating Lease Non Cash Lease Expense-
Amortization Of Operating Lease Right Of Use Assets-
Operating Lease Right Of Use Asset Amortization Expense0.43
Investment Income Net Amortization Of Discount And Premium-0.01
Income taxes0.00
Gain (Loss) on Sale of Other Investments-1.04
Increase (Decrease) in Accounts Receivable0.00
Increase (Decrease) in Accounts Payable and Accrued Liabilities0.53
Increase (Decrease) in Other Accrued Liabilities0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.63
Other Working Capital-0.10
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities1.94
Discontinued operations0.00
Net Cash flow from Operating Activities-39.64
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Short-term Investments Proceeds8.78
Short-term Investments Acq.0.00
Real Estate Investments0.00
Proceeds From Sale Of Equity Securities Fv Ni-
Increase (Decrease) in Restricted Cash0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Payments to Acquire Additional Interest in Subsidiaries0.00
Cash Divested from Deconsolidation0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities8.78
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock4.33
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock13.96
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-0.19
Proceeds from Stock Option and Warrant Exercises-
Proceeds From Payments For Stock Options Exercised and Exercise Of Warrants Net Of Tax Withholdings-
Proceeds From Payments For Stock Options Exercised And Exercise Of Warrants Net Of Tax Withholdings-0.13
Proceeds From Issuance Of Warrants Net Of Issuance Costs-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities18.11
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-39.64
Total Cash Flow-12.75
4 historic quarters locked

Sign in to unlock the full Inovio Pharmaceuticals Inc cash flow history.

Sign In Create Free Account

About Inovio Pharmaceuticals Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 12, 2026
  • Source: ino-20260630.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001055726-26-000023

Figures are derived from filed reports and may be restated. Historical data is subject to revision.